EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions
13/10/2026 15:10
EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions BRUSSELS, Oct 13 (Reuters) - The European Commission on Tuesday approved Kimberly-Clark KMB.O's acquisition of Tylenol maker Kenvue KVUE.N after the maker of Kleenex tissues and Huggies diapers offered concessions to address EU antitrust concerns.
Kimberly-Clark offered to sell all its tampon and other feminine hygiene brands in the European Economic Area, the Commission, which act as the EU competition enforcer, said in a statement.
"The brands covered by the divestment are Kotex (including the Lidie sub-brand), Camelia, and Record", it said.
(Reporting by Charlotte Van Campenhout, Editing by Inti Landauro)
((Charlotte.VanCampenhout@thomsonreuters.com; X: @CVanCampenhout / bsky:@charlottevc.bsky.social;))
Recent news on Kenvue
See all newsBrief: Kenvue To Announce Third Quarter 2026 Results On October 30, 2026
Brief: Kimberly-Clark Corporation Announces Pricing Of $4.9 Billion Private Offering Of Senior Notes
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Media: Kimberly-Clark offers bonds to help fund Kenvue takeover - Bloomberg News
US stocks weekly: AI unwind